Vaxxinity Statistics
Total Valuation
Vaxxinity has a market cap or net worth of $10.27 million. The enterprise value is -$5.06 million.
Market Cap | 10.27M |
Enterprise Value | -5.06M |
Important Dates
The last earnings date was Tuesday, May 14, 2024, before market open.
Earnings Date | May 14, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Vaxxinity has 126.78 million shares outstanding. The number of shares has increased by 0.54% in one year.
Shares Outstanding | 126.78M |
Shares Change (YoY) | +0.54% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 50.91% |
Owned by Institutions (%) | 10.86% |
Float | 55.31M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.77 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.89, with a Debt / Equity ratio of 1.13.
Current Ratio | 1.89 |
Quick Ratio | 1.76 |
Debt / Equity | 1.13 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | 40.65 |
Financial Efficiency
Return on equity (ROE) is -424.51% and return on invested capital (ROIC) is -204.12%.
Return on Equity (ROE) | -424.51% |
Return on Assets (ROA) | -128.34% |
Return on Capital (ROIC) | -204.12% |
Revenue Per Employee | n/a |
Profits Per Employee | -$998,649 |
Employee Count | 57 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, Vaxxinity has paid $310,000 in taxes.
Income Tax | 310,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -96.01% in the last 52 weeks. The beta is 2.80, so Vaxxinity's price volatility has been higher than the market average.
Beta (1Y) | 2.80 |
52-Week Price Change | -96.01% |
50-Day Moving Average | 0.43 |
200-Day Moving Average | 0.98 |
Relative Strength Index (RSI) | 29.08 |
Average Volume (30 Days) | 2,275,998 |
Short Selling Information
The latest short interest is 4.22 million, so 3.33% of the outstanding shares have been sold short.
Short Interest | 4.22M |
Short Previous Month | 4.08M |
Short % of Shares Out | 3.33% |
Short % of Float | 7.63% |
Short Ratio (days to cover) | 13.97 |
Income Statement
Revenue | n/a |
Gross Profit | -2.23M |
Operating Income | -58.33M |
Pretax Income | -56.94M |
Net Income | -56.92M |
EBITDA | -54.44M |
EBIT | -56.67M |
Earnings Per Share (EPS) | -$0.45 |
Balance Sheet
The company has $30.50 million in cash and $15.17 million in debt, giving a net cash position of $15.33 million or $0.12 per share.
Cash & Cash Equivalents | 30.50M |
Total Debt | 15.17M |
Net Cash | 15.33M |
Net Cash Per Share | $0.12 |
Equity / Book Value | 13.41M |
Book Value Per Share | 0.11 |
Working Capital | 15.62M |
Cash Flow
In the last 12 months, operating cash flow was -$57.24 million and capital expenditures -$803,000, giving a free cash flow of -$58.04 million.
Operating Cash Flow | -57.24M |
Capital Expenditures | -803,000 |
Free Cash Flow | -58.04M |
FCF Per Share | -$0.46 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Vaxxinity does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.54% |
Shareholder Yield | -0.54% |
Earnings Yield | -554.29% |
FCF Yield | -565.17% |
Analyst Forecast
The average price target for Vaxxinity is $7.00, which is 8,541.98% higher than the current price. The consensus rating is "Buy".
Price Target | $7.00 |
Price Target Difference | 8,541.98% |
Analyst Consensus | Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |